Ching Jaw

Ching Jaw

Plus aucun poste en cours

Fortune : 6 M $ au 31/03/2024

61 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Ching W.
Jaw
worked as Head-Finance at Genentech, Inc. and as Chief Financial Officer at Ventana Medical Systems, Inc. from 2012 to 2015.
He also worked as Chief Financial Officer & Senior Vice President at Cytokinetics, Inc. from 2017 to 2024.
In addition, he held the position of Chief Financial Officer-North America at Sanofi SA from 2015 to 2017 and was the Chief Financial Officer at Roche Products Ltd.
(Taiwan).
Prior to his career in finance, he earned an undergraduate degree from National Taiwan University and a graduate degree from the University of Michigan.
He also holds an MBA from The University of Chicago Booth School of Business.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
06/03/2023 87 346 ( 0,08% ) 6 M $ 31/03/2024

Anciens postes connus de Ching Jaw

SociétésPosteFin
CYTOKINETICS, INCORPORATED Director of Finance/CFO 23/02/2024
Sanofi SA Corporate Officer/Principal 01/01/2017
Director of Finance/CFO 01/01/2015
Corporate Officer/Principal 01/01/2002
Roche Products Ltd. (Taiwan) Director of Finance/CFO -
Voir l'expérience en détail de Ching Jaw

Formation de Ching Jaw

University of Michigan Graduate Degree
National Taiwan University Undergraduate Degree
The University of Chicago Booth School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ching Jaw

Relations

38

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CYTOKINETICS, INCORPORATED

Health Technology

Entreprise privées5

Health Technology

Electronic Technology

Finance

Sanofi SA

Health Technology

Roche Products Ltd. (Taiwan)

Voir les connexions sociétés